Cat.#: ACPP-1583
| Despition | NRTN Human Recombinant |
| SIZE | 5 µg |
| Purity | > 96.0% (SDS-PAGE) |
| Form | Sterile Filtered White lyophilized (freeze-dried) powder. |
| Storage | Lyophilized was stored and desiccated below -18°C. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1316 | GPCR GPR7 Blocking Peptide (AC1316) | 250 µg | inquiry |
| ACPP-1837 | Rat SCGN Protein (AC1837) | 2 µg | inquiry |
| ACPP-1592 | Human CRYAB Protein (AC1592) | 20 µg | inquiry |
| ACPP-1183 | Recombinant Human GIPR Protein (Fc Tag) (AC1183) | 50 µg | inquiry |
| ACPP-1690 | Human PDE6H Protein (AC1690) | 2 µg | inquiry |
| ACPP-1230 | MC3 Receptor Blocking Peptide (AC1230) | 250 µg | inquiry |
| ACPP-1024 | Recombinant Human FGF2 Protein (mutated Q65I + C96S + N111G). (AC1024) | 50 µg | inquiry |
| ACPP-1308 | TrkA Blocking Peptide (AC1308) | 250 µg | inquiry |
| ACPP-1526 | Human KCTD11 Protein (AC1526) | 2 µg | inquiry |
| ACPP-1680 | Human DOK4 Protein (AC1680) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.